Facebook
X
LinkedIn
Forward| Ferring Pharmaceuticals - Exhibitor | |
|---|---|
Contact information Tim Johnson Larry Newton | The first and only single-dose microbiota-based live biotherapeutic approved to prevent recurrence of C. difficile infection starting at first recurrence. Additional Information: |
